Shwe, T.H.; Pothacharoen, P.; Phitak, T.; Wudtiwai, B.; Kongtawelert, P.
Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2021, 22, 8755.
https://doi.org/10.3390/ijms22168755
AMA Style
Shwe TH, Pothacharoen P, Phitak T, Wudtiwai B, Kongtawelert P.
Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. 2021; 22(16):8755.
https://doi.org/10.3390/ijms22168755
Chicago/Turabian Style
Shwe, Thuzar Hla, Peraphan Pothacharoen, Thanyaluck Phitak, Benjawan Wudtiwai, and Prachya Kongtawelert.
2021. "Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells" International Journal of Molecular Sciences 22, no. 16: 8755.
https://doi.org/10.3390/ijms22168755
APA Style
Shwe, T. H., Pothacharoen, P., Phitak, T., Wudtiwai, B., & Kongtawelert, P.
(2021). Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences, 22(16), 8755.
https://doi.org/10.3390/ijms22168755